Making ambulatory blood pressure monitoring accessible in pharmacies

Blood Pressure Monitoring

Volumn 19, Issue 3, 2014, Pages 134-139

  James, Kirstyn ^a   Dolan, Eamon ^a   O'Brien, Eoin ^b  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

ambulatory blood pressure measurement; pharmacy; primary care

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CLINICAL ASSESSMENT; CLINICAL PHARMACY; COMPARATIVE STUDY; COMPUTER PROGRAM; FEMALE; HUMAN; HYPERTENSION; IRELAND; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PATIENT ASSESSMENT; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; INFORMATION PROCESSING; PATHOPHYSIOLOGY; PHARMACY; PRIMARY HEALTH CARE; WHITE COAT HYPERTENSION;

AUTOMATIC DATA PROCESSING; BLOOD PRESSURE MONITORING, AMBULATORY; FEMALE; HUMANS; MALE; PHARMACY; PRIMARY HEALTH CARE; SOFTWARE; WHITE COAT HYPERTENSION;

EID: 84900451070     PISSN: 13595237     EISSN: 14735725     Source Type: Journal    
DOI: 10.1097/MBP.0000000000000034     Document Type: Article

References (22)

1. World Health Organization. Global status report on noncommunicable diseases 2010. Geneva, Switzerland: WHO; 2010.
2. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease study 2010. Lancet 2012; 380:2224-2260.
3. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee On Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42:1206-1252.
4. National Institute for Health and Clinical Excellence (NICE). Hypertension. The clinical management of primary hypertension in adults. Clinical Guideline 127. London, UK: NICE 2011; Available at: http:// www.nice.org.uk/guidance/CG127. [Accessed 10 December 2013].
5. O'Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G, et al. on behalf of the European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens 2013; 31:1731-1767.
6. Lovibond K, Jowett S, Barton P, Caulfield M, Heneghan C, Hobbs FDR, et al. Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modeling study. Lancet 2011; 378:1219-1230.
7. O'Brien E, Mee F, Atkins N, O'Malley K. Accuracy of the Spacelabs 90 207 determined by to the British Hypertension Society Protocol. J Hypertens 1991; 9 (Suppl 5):S25-S31.
8. Barna I, Keszei A, Dunai A. Evaluation of Meditech ABPM-04 ambulatory blood pressure measuring device according to the British Hypertension Society protocol. Blood Press Monit 1998; 3:363-368.
9. O'Brien E, Asmar R, Beilin L, Bilo G, de Leeuw P, Imai Y, et al. on behalf of the European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003; 21:821-848.
10. O'Brien E, Atkins N. Can improved software facilitate the wider use of ambulatory blood pressure measurement in clinical practice? Blood Press Monit 2004; 9:237-241.
11. O'Brien E. 24-hour ambulatory blood pressure measurement in clinical practice and research: a critical review of a technique in need of implementation. J Inter Med 2011; 269:478-495.
12. McGowan N, Atkins N, O'Brien E, Padfield P. Computerised reporting improves the clinical use of ambulatory blood pressure measurement. Blood Press Monit 2010; 15:115-123.
13. O'Brien E. First Thomas Pickering memorial lecture: ambulatory blood pressure measurement is essential for the management of hypertension. J Clin Hypertens 2012; 14:836-847.
14. James K, Salvi L, Leahy A, Dolan E, O'Brien E. The profile of patients having ambulatory blood pressure monitoring in a pharmacy setting. J Hypertens 2013; 31 (e-Suppl A):e21.
15. Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low density lipoprotein cholesterol: a randomized controlled trial. JAMA 2006; 296:2563-2571.
16. Weber CA, Ernst ME, Sezate GS, Zheng S, Carter BL. Pharmacistphysician co-management of hypertension and reduction in 24-hour ambulatory blood pressures. Arch Intern Med 2010; 170:1634-1639.
17. Sendra-Lillo J, Sabater-Hernandez D, Sendra-Ortola A, Martinez-Martinez F. Agreement between community pharmacy, physician's office, and home blood pressure measurement methods: the Palmera study. Am J Hypertens 2012; 25:290-296.
18. Carter BL, Foppe van Mil JW. Comparative effectiveness research: evaluating pharmacist interventions and strategies to improve medication adherence. Am J Hypertens 2010; 23:949-955.
19. Heisler M, Hofer TP, Schmittdiel JA, Selby JV, Klamerus ML, Bosworth HB, et al. Improving blood pressure control through a clinical pharmacist outreach program in diabetes patients in two-high performing health systems: the adherence and intensification of medications (AIM) cluster randomized controlled pragmatic trial. Circulation 2012; 125: 2863-2872.
20. Margolis KL, Asche SE, Bergdall AR, Dehmer SP, Groen SE, Kadrmas HM, et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control. A cluster randomized clinical trial. JAMA 2013; 310:46-56.
21. Vanderveen P. How to care for 30 million more patients. Wall Street J 2010.
22. James K, Dolan E, O'Brien E. Insights from a large national database of ambulatory blood pressure monitoring: ABPM population study in Ireland (APSI study). J Hypertens 2013; 31 (Suppl A):e67.